Efficacy and Safety of Anti–Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison

Background: We aimed to evaluate the comparative efficacy and safety of anti–vascular endothelial growth factor (anti-VEGF) monotherapy to identify its utilization and prioritization in patients with neovascular age-related macular degeneration (nAMD). Methods: Eligible studies included randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun, Gao, Sheng, Li, Xun, Huang, Xi, Zhang, Yi, Chang, Tiancong, Cai, Zhaolun, Zhang, Meixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724554/
https://www.ncbi.nlm.nih.gov/pubmed/34992542
http://dx.doi.org/10.3389/fphar.2021.797108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724554/
https://www.ncbi.nlm.nih.gov/pubmed/34992542
http://dx.doi.org/10.3389/fphar.2021.797108

Ejemplares similares